Penserra Capital Management LLC Myriad Genetics Inc Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$24.13 - $32.63 $43,072 - $58,244	-1,785 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$29.97 - $36.66 $899 - $1,099	30 Added 1.71%	1,785 $57,000
Q2 2021 Aug 12, 2021	BUY	$25.39 - $32.61 $1,396 - $1,793	55 Added 3.24%	1,755 $53,000
Q1 2021 May 13, 2021	SELL	$19.92 - $31.6 $996 - $1,580	-50 Reduced 2.86%	1,700 $51,000
Q4 2020 Feb 12, 2021	BUY	$12.16 - $19.77 $13,521 - $21,984	1,112 Added 174.29%	1,750 $34,000
Q3 2020 Nov 13, 2020	BUY	$11.25 - $14.75 $7,177 - $9,410	638 New	638 $8,000

230

88.9M

43.5K

18.1K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.17B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.